0001178913-26-003083.txt : 20260603 0001178913-26-003083.hdr.sgml : 20260603 20260603161905 ACCESSION NUMBER: 0001178913-26-003083 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260601 FILED AS OF DATE: 20260603 DATE AS OF CHANGE: 20260603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Melincoff Gwen A CENTRAL INDEX KEY: 0001614890 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38807 FILM NUMBER: 261060910 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: C/O PROTALIX BIOTHERAPEUTICS, INC. STREET 2: 2 SNUNIT STREET, SCIENCE PARK CITY: CARMIEL PROVINCE COUNTRY: L3 ZIP: 2161401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Chemomab Therapeutics Ltd. CENTRAL INDEX KEY: 0001534248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 813676773 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: KIRYAT ATIDIM, BUILDING 7 CITY: TEL AVIV PROVINCE COUNTRY: L3 BUSINESS PHONE: 972-77-331-0156 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: KIRYAT ATIDIM, BUILDING 7 CITY: TEL AVIV PROVINCE COUNTRY: L3 FORMER COMPANY: FORMER CONFORMED NAME: Anchiano Therapeutics Ltd. DATE OF NAME CHANGE: 20180906 FORMER COMPANY: FORMER CONFORMED NAME: BioCancell Ltd. DATE OF NAME CHANGE: 20111104 3 1 zk2635486.xml FORM 3 X0607 3 2026-06-01 0 0001534248 Chemomab Therapeutics Ltd. CMMB 0001614890 Melincoff Gwen A true C/O CHEMOMAB THERAPEUTICS LTD. 10 HABARZEL ST. BUILDING C, 10TH FLOOR TEL AVIV L3 6158101 ISRAEL 1 0 0 0 Stock option (right to buy American Depositary Shares) 1.86 2026-06-01 2036-06-01 American Depositary Shares 8621 D The option reported in this row was granted to the Reporting Person by the Issuer on June 1, 2026 and vests and becomes exercisable in equal monthly installments over a 36-month period, commencing on June 1, 2026. /s/ Gwen Melincoff 2026-06-03